Abstract

BackgroundThe establishment of a suitable and stable animal model is critical for research on thyroid-associated ophthalmopathy (TAO). In clinical practice, we found that patients treated with I-131 often exhibit TAO; therefore, we aimed to establish a novel thyroid function fluctuated animal model of TAO by simulating the clinical treatment process.MethodsWe treated SD rats with I-131 to damage the thyroid and then used sodium levothyroxine (L-T4) to supplement the thyroid hormone (TH) levels every seven days, leading to a fluctuating level of thyroid hormones that simulated the status of clinical TAO patients. Rats administered normal saline were considered as a control. The weight, intraocular pressure, and serum T3, T4, TSH and TRAb levels of the rats were measured, and the pathological changes were analyzed by H&E staining and transmission electron microscopy (TEM).ResultsThe experimental rats (TAO group) exhibited significantly reduced weight and elevated intraocular pressure compared with the control rats. Meanwhile, the serum levels of T3 and T4 were up-regulated in the TAO group, but the TSH level decreased during the 10-week study. Moreover, increased numbers of blood vessels and inflammatory cell infiltrations were observed in the orbital tissues of the TAO rats, while no abnormal changes occurred in the control rats. The orbital myofibrils in the TAO rats appeared fractured and dissolved, with twisted structures. Mitochondrial swelling and vacuoles within the endoplasmic reticulum, swelling nerve fibers, shedding nerve myelin, and macrophages were found in the TAO group.ConclusionRats treated with I-131 and sodium levothyroxine exhibited characteristics similar to those of TAO patients in the clinic, providing an effective and simple method for the establishment of a stable animal model for research on the pathogenesis and treatment of TAO.

Highlights

  • Thyroid-associated ophthalmopathy (TAO) is an autoimmune disorder of the orbit that is closely related to Graves’ disease [1], which has a high morbidity rate in adult patients with orbital disease

  • We found that patients treated with I131 often exhibit TAO; we aimed to establish a novel thyroid function fluctuated animal model of TAO by simulating the clinical treatment process

  • The serum levels of T3 and T4 were up-regulated in the TAO group, but the TSH level decreased during the 10-week study

Read more

Summary

Introduction

Thyroid-associated ophthalmopathy (TAO) is an autoimmune disorder of the orbit that is closely related to Graves’ disease [1], which has a high morbidity rate in adult patients with orbital disease. The orbital tissues, the extraocular muscles and retro-orbital fat tissue, are two major sites of involvement in thyroid-associated ophthalmopathy (TAO). It is important to establish a stable animal model for research on the pathogenesis and prevention of TAO in the clinic. The establishment of a suitable and stable animal model is critical for research on thyroidassociated ophthalmopathy (TAO). We found that patients treated with I131 often exhibit TAO; we aimed to establish a novel thyroid function fluctuated animal model of TAO by simulating the clinical treatment process

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call